Zenon™ pHrodo™ iFL IgG Labeling Reagents
Zenon™ pHrodo™ iFL IgG Labeling Reagents
Zenon™ pHrodo™ iFL IgG Labeling Reagents
Zenon™ pHrodo™ iFL IgG Labeling Reagents
Zenon™ pHrodo™ iFL IgG Labeling Reagents
Invitrogen™

Zenon™ pHrodo™ iFL IgG Labeling Reagents

Zenon™ pHrodo™ iFL Green-labeled or Red-labeled Fab fragments (i.e. labeling reagent) are directed against the Fc portion of an intact IgG primary antibody to form a labeling complex.
Have Questions?
Change viewbuttonViewtableView
Catalog NumberQuantitySpeciesLabel or DyeColor
Z25611250 μLHumanpHrodo iFL GreenGreen
Z25618250 μLHumanpHrodo Deep RedDeep Red
Z25622250 μLMousepHrodo Deep RedDeep Red
Z25612250 μLHumanpHrodo iFL RedRed
Z25610250 μLMousepHrodo iFL RedRed
Z25609250 μLMousepHrodo iFL GreenGreen
Z256231.2 mLHumanpHrodo Deep RedDeep Red
Z256141.2 mLHumanpHrodo iFL RedRed
Z256131.2 mLHumanpHrodo iFL GreenGreen
Z256241.2 mLMousepHrodo Deep RedDeep Red
Z256261.2 mLMousepHrodo RedRed
Z256251.2 mLMousepHrodo GreenGreen
Catalog number Z25611
Price (MXN)
-
Quantity:
250 μL
Species:
Human
Label or Dye:
pHrodo iFL Green
Color:
Green
Streamline antibody-drug conjugate screening campaigns with Invitrogen Zenon pHrodo IgG Labeling Reagents to screen for antibody internalization. These reagents provide rapid, scalable antibody labeling and give a bright fluorescence-based indication of antibody uptake and trafficking in target cells when analyzed by flow cytometry, fluorescence microscopy, or high-content screening.

Zenon™ pHrodo™ iFL Green-labeled or Red-labeled Fab fragments (i.e. labeling reagent) are directed against the Fc portion of an intact IgG primary antibody to form a labeling complex. Formation of the Fab–antibody complex occurs in fewer than 5 minutes. Because the pHrodo™ iFL dyes dramatically increase in fluorescence as the pH of their surroundings becomes more acidic, the antibodies coupled with the Zenon™ pHrodo™ iFL IgG Labeling Reagents provide an excellent measure of endocytic activity based on the acidification of the labeled antibodies as they are ingested by the cell.

The Zenon™ pHrodo™ iFL IgG Labeling Reagents contain sufficient material to label one to four 96-well plates, depending on the Zenon™ labeling reagent concentration used. Only a small amount of starting material is needed, and the method is optimized for efficient labeling of antibodies in serum, ascites fluid, or hybridoma suspensions.

Other advantages of the pH-sensitive Zenon™ pHrodo™ iFL IgG Labeling Reagents include:

  • Simplicity—No reagent purification is required
  • Accuracy—No wash steps or quenchers are needed, minimizing cross-reactivity or background
  • Speed—Labeled antibodies are typically ready to use in 10 minutes
  • Specificity—Dyes are designed for the specific detection of phagocytosis and endocytosis

Preserve primary antibody function and affinities

Reactive dye labeling of primary antibodies can have unpredictable and undesirable outcomes. One of these is reduced binding affinity due to label addition in the binding pocket. The Zenon™ antibody labeling approach, which is targeted to the Fc tail, resolves this potential issue.

Try custom antibody conjugates

If the antibody conjugate you need is not available as one of our stocked products, we will prepare a custom antibody conjugate for you. Our custom conjugation service is efficient and confidential, and we stand by the quality of our work. We are ISO 13485:2000 certified.

For Research Use Only. Not intended for animal or human therapeutic or diagnostic use.

For Research Use Only. Not for use in diagnostic procedures.
Specifications
ColorGreen
DescriptionpHrodo™ iFL Green, 240 μL
Excitation/Emission505/530 nm
Kit Contents1 vial of Zenon™ pHrodo™ iFL Green human labeling reagent (250 μL)
Label TypepHrodo™ (pH sensitive)
Product LineZenon
Product TypeLabeling Reagent
Quantity250 μL
SpeciesHuman
Labeling TargetIgG
Label or DyepHrodo iFL Green
Unit Size250 μL
Contents & Storage
Store in refrigerator (2°C to 8°C) and protect from light

Citations & References (3)

Citations & References
Abstract
LILRA2 selectively modulates LPS-mediated cytokine production and inhibits phagocytosis by monocytes.
Authors:Lu HK, Mitchell A, Endoh Y, Hampartzoumian T, Huynh O, Borges L, Geczy C, Bryant K, Tedla N
Journal:PLoS One
PubMed ID:22479404
'The activating immunoglobulin-like receptor, subfamily A, member 2 (LILRA2) is primarily expressed on the surface of cells of the innate immunity including monocytes, macrophages, neutrophils, basophils and eosinophils but not on lymphocytes and NK cells. LILRA2 cross-linking on monocytes induces pro-inflammatory cytokines while inhibiting dendritic cell differentiation and antigen presentation. ... More
High Affinity Promotes Internalization of Engineered Antibodies Targeting FGFR1.
Authors:Opalinski L, Szymczyk J, Szczepara M, Kucinska M, Krowarsch D, Zakrzewska M, Otlewski J
Journal:Int J Mol Sci
PubMed ID:29748524
Fibroblast growth factor receptor 1 (FGFR1) is a plasma membrane protein that transmits signals from the extracellular environment, regulating cell homeostasis and function. Dysregulation of FGFR1 leads to the development of human cancers and noncancerous diseases. Numerous tumors overproduce FGFR1, making this receptor a perspective target for cancer therapies. Antibody-drug ... More
Novel Silyl Ether-Based Acid-Cleavable Antibody-MMAE Conjugates with Appropriate Stability and Efficacy.
Authors:Wang Y, Fan S, Xiao D, Xie F, Li W, Zhong W, Zhou X,
Journal:Cancers (Basel)
PubMed ID:31288450
Antibody-drug conjugate (ADC) is a novel efficient drug delivery system that has been successfully used in clinical practice, and it has become a research hotspot in the anti-tumor drug field. Acid-cleavable linkers were first used in clinical ADCs, but their structural variety (e.g., hydrazone and carbonate) is still limited, and ... More